Trump Fast-Tracks Psychedelic Research

In a significant shift in federal drug policy, President Trump has authorized $50 million for research into formerly 'taboo' substances for medical use.

The executive order specifically targets breakthrough therapies for veterans suffering from mental health disorders and brain trauma.

Joe Rogan was present in the Oval Office for the signing, having reportedly texted the President to advocate for the clinical benefits of ibogaine.

While the drugs remain in the most restrictive federal category, the administration is easing restrictions to spur innovation in depression and PTSD treatments.